Table 1 Cell cycle analysis of glioblastoma cell lines after treatment with 7-epiclusianone
From: Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma
| Â | U251MG | U138MG | ||
|---|---|---|---|---|
Sub-G1 (%) | ||||
 Control | 6.35 | ±0.92 | 6.45 | ±3.68 |
 10 μM | 5.92 | ±3.00 | 13.98 | ±6.14 |
 20 μM | 7.80 | ±1.00 | 12.99 | ±0.81 |
 30 μM | 9.88 | ±1.09 | 15.66 | ±2.82 |
 40 μM | 14.74 | ±0.94* | 22.50 | ±2.45* |
G1 (%) | ||||
 Control | 54.97 | ±2.76 | 65.54 | ±3.86 |
 10 μM | 68.94 | ±2.34* | 65.70 | ±4.20 |
 20 μM | 59.67 | ±3.82 | 55.99 | ±0.54* |
 30 μM | 57.02 | ±2.97 | 54.92 | ±0.68* |
 40 μM | 45.77 | ±1.49* | 50.72 | ±2.58* |
S (%) | ||||
 Control | 5.07 | ±1.07 | 6.83 | ±0.73 |
 10 μM | 3.59 | ±1.63 | 4.32 | ±0.76* |
 20 μM | 6.77 | ±0.41 | 7.44 | ±0.75 |
 30 μM | 6.93 | ±0.39 | 7.45 | ±0.92 |
 40 μM | 6.23 | ±1.92 | 4.74 | ±0.17* |
G2/M (%) | ||||
 Control | 33.79 | ±2.34 | 21.24 | ±0.50 |
 10 μM | 21.36 | ±1.05* | 17.25 | ±3.05* |
 20 μM | 25.44 | ±2.99* | 23.51 | ±0.90 |
 30 μM | 26.10 | ±1.66* | 22.32 | ±3.65 |
 40 μM | 33.62 | ±2.28 | 21.99 | ±1.92 |